服務熱線
021-60498804
| Cat. Number | B1746 |
| Chemical Name | B1746 BELINOSTAT 414864-00-9 |
| CAS Number | 414864-00-9 |
| Mol. Formula | C15H14N2O4S |
| Mol. Weight | 318.35 |
| Qty 1 |
5mg |
| Qty 2 | 10mg |
| Appearance | Pale yellow powder |
| Application Notes | ≥98% |
| Synonym | PXD101 |
| Solubility | DMSO 64 mg/mL (201.03 mM) Water Insoluble Ethanol Insoluble |
| Storage condition | -20°C |
| References | Belinostat is a histone deacetylase (HDAC) inhibitor that exhibits antiviral and anticancer chemotherapeutic activities. Belinostat is approved for use in humans in the treatment of T cell lymphoma and is currently in clinical trials as a potential treatment for other leukemias and lymphomas. In pancreatic cancer cells, belinostat induces apoptosis in an AMPK-dependent manner. In other cellular models, this compound decreases HIV release from macrophages by degrading intracellular HIV. ReferencesCampbell GR, Bruckman RS, Chu YL, et al. Autophagy Induction by Histone Deacetylase Inhibitors Inhibits HIV Type 1. J Biol Chem. 2015 Feb 20;290(8):5028-40. PMID: 25540204. Foss F, Advani R, Duvic M, et al. A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma. Br J Haematol. 2014 Nov 17. [Epub ahead of print]. Kirschbaum MH, Foon KA, Frankel P, et al. A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study. Leuk Lymphoma. 2014 Oct;55(10):2301-4. PMID: 24369094. Wang B, Wang XB, Chen LY, et al. Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axis. Biochem Biophys Res Commun. 2013 Jul 19;437(1):1-6. PMID: 23743198. |
下一個：BUTYRIC ACID SODIUM上一個：APICIDIN |
|
Copyright ? 2022 上?；菡\生物科技有限公司
滬ICP備2021037845號-6
